Antiretroviral therapy in the private sector of Nairobi, Kenya
- 1 April 2003
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in AIDS
- Vol. 17 (6), 938-940
- https://doi.org/10.1097/00002030-200304110-00028
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- The Senegalese government's highly active antiretroviral therapy initiative: an 18-month follow-up studyAIDS, 2002
- Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistanceThe Lancet, 2002
- Overcoming challenges to the implementation of antiretroviral therapy in Kenya.The Lancet Infectious Diseases, 2002
- Randomized, double-blind comparison of two nelfinavir doses plus nucleosides in HIV-infected patients (Agouron study 511)AIDS, 2001
- HIV/AIDS Treatment for MillionsScience, 2001
- Highly Active Antiretroviral Therapy in a Large Urban Clinic: Risk Factors for Virologic Failure and Adverse Drug ReactionsAnnals of Internal Medicine, 1999
- A Randomized, Double-blind Trial Comparing Combinations of Nevirapine, Didanosine, and Zidovudine for HIV-Infected PatientsJama-Journal Of The American Medical Association, 1998